| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
-Hydroxylase in the Human Kidney


*
Division of Medical Sciences, University of Birmingham, Queen Elizabeth
Hospital, Edgbaston, Birmingham, United Kingdom.
Division of Immunology and Infection, University of Birmingham, Queen
Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom.
Department of Pathology, University of Birmingham, Queen Elizabeth
Hospital, Edgbaston, Birmingham, United Kingdom.
Correspondence to Dr. Paul M. Stewart, Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, United Kingdom. Phone: +44 121 627 2381; Fax: +44 121 627 2384; E-mail: P.M.Stewart{at}bham.ac.uk
Abstract. The secosteroid hormone 1,25-dihydroxyvitamin
D3 (1,25(OH)2D3) plays a vital role in
calcium metabolism, tissue differentiation, and normal bone growth.
Biosynthesis of 1,25(OH)2D3 is catalyzed by the
mitochondrial cytochrome P450 enzyme 25-hydroxyvitamin D3
1
-hydroxylase (1
-hydroxylase). Although activity of this enzyme
has been described in several tissues, the kidneys are recognized to be the
principal site of 1,25(OH)2D3 production. To date,
enzyme activity studies using vitamin D-deficient animals have suggested that
1
-hydroxylase is expressed exclusively in proximal convoluted tubules.
With the recent cloning of 1
-hydroxylase, specific cRNA probes and
in-house polyclonal antiserum have been used to determine the distribution of
1
-hydroxylase along the human nephron. Immunohistochemistry and in
situ hybridization studies indicated strong expression of
1
-hydroxylase protein and mRNA in the distal convoluted tubule, the
cortical and medullary part of the collecting ducts, and the papillary
epithelia. Lower expression was observed along the thick ascending limb of the
loop of Henle and Bowman's capsule. Weaker and more variable expression of
1
-hydroxylase protein and mRNA was seen in proximal convoluted tubules,
and no expression was observed in glomeruli or vascular structures. These data
show for the first time the distribution of 1
-hydroxylase expression in
normal human kidney. In contrast to earlier enzyme activity studies conducted
in vitamin D-deficient animals, our data indicate that the distal nephron is
the predominant site of 1
-hydroxylase expression under conditions of
vitamin D sufficiency.
This article has been cited by other articles:
![]() |
S. Hansdottir, M. M. Monick, S. L. Hinde, N. Lovan, D. C. Look, and G. W. Hunninghake Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense J. Immunol., November 15, 2008; 181(10): 7090 - 7099. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Forman, G. C. Curhan, and E. N. Taylor Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension Among Young Women Hypertension, November 1, 2008; 52(5): 828 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maiti, N. C. Hait, and M. J. Beckman Extracellular Calcium-sensing Receptor Activation Induces Vitamin D Receptor Levels in Proximal Kidney HK-2G Cells by a Mechanism That Requires Phosphorylation of p38{alpha} MAPK J. Biol. Chem., January 4, 2008; 283(1): 175 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zasloff Antimicrobial Peptides, Innate Immunity, and the Normally Sterile Urinary Tract J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2810 - 2816. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Molostvov, S. James, S. Fletcher, J. Bennett, H. Lehnert, R. Bland, and D. Zehnder Extracellular calcium-sensing receptor is functionally expressed in human artery Am J Physiol Renal Physiol, September 1, 2007; 293(3): F946 - F955. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Forman, E. Giovannucci, M. D. Holmes, H. A. Bischoff-Ferrari, S. S. Tworoger, W. C. Willett, and G. C. Curhan Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension Hypertension, May 1, 2007; 49(5): 1063 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van Driel, M. Koedam, C. J. Buurman, M. Hewison, H. Chiba, A. G. Uitterlinden, H. A. P. Pols, and J. P. T. M. van Leeuwen Evidence for auto/paracrine actions of vitamin D in bone: 1{alpha}-hydroxylase expression and activity in human bone cells FASEB J, November 1, 2006; 20(13): 2417 - 2419. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Vanhooke, J. M. Prahl, C. Kimmel-Jehan, M. Mendelsohn, E. W. Danielson, K. D. Healy, and H. F. DeLuca CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1{alpha}-hydroxylase promoter activity in the skin PNAS, January 3, 2006; 103(1): 75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Townsend, C. M. Banwell, M. Guy, K. W. Colston, J. L. Mansi, P. M. Stewart, M. J. Campbell, and M. Hewison Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue Clin. Cancer Res., May 1, 2005; 11(9): 3579 - 3586. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Bachschmid and B. van der Loo A New "Sunshine" in the Vasculature? Circulation, April 5, 2005; 111(13): 1571 - 1573. [Full Text] [PDF] |
||||
![]() |
D. Somjen, Y. Weisman, F. Kohen, B. Gayer, R. Limor, O. Sharon, N. Jaccard, E. Knoll, and N. Stern 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds Circulation, April 5, 2005; 111(13): 1666 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Hendrix, P H Anderson, J L Omdahl, B K May, and H A Morris Response of the 5'-flanking region of the human 25-hydroxyvitamin D 1{alpha}-hydroxylase gene to physiological stimuli using a transgenic mouse model J. Mol. Endocrinol., February 1, 2005; 34(1): 237 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M T Abreu, V Kantorovich, E A Vasiliauskas, U Gruntmanis, R Matuk, K Daigle, S Chen, D Zehnder, Y-C Lin, H Yang, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density Gut, August 1, 2004; 53(8): 1129 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yuan, Y. Xing, R. L. Horst, and M. K. Drezner Evidence for Abnormal Translational Regulation of Renal 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Activity in the Hyp-Mouse Endocrinology, August 1, 2004; 145(8): 3804 - 3812. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Evans, J. N. Bulmer, M. D. Kilby, and M. Hewison Vitamin D and Placental-Decidual Function Reproductive Sciences, July 1, 2004; 11(5): 263 - 271. [Abstract] [PDF] |
||||
![]() |
J. B. Cheng, M. A. Levine, N. H. Bell, D. J. Mangelsdorf, and D. W. Russell Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase PNAS, May 18, 2004; 101(20): 7711 - 7715. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsujikawa, Y. Kurotaki, T. Fujimori, K. Fukuda, and Y.-I. Nabeshima Klotho, a Gene Related to a Syndrome Resembling Human Premature Aging, Functions in a Negative Regulatory Circuit of Vitamin D Endocrine System Mol. Endocrinol., December 1, 2003; 17(12): 2393 - 2403. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rauz, C.M.G. Cheung, P.J. Wood, M. Coca-Prados, E.A. Walker, P.I. Murray, and P.M. Stewart Inhibition of 11{beta}-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension QJM, July 1, 2003; 96(7): 481 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zehnder, K. N. Evans, M. D. Kilby, J. N. Bulmer, B. A. Innes, P. M. Stewart, and M. Hewison The Ontogeny of 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Expression in Human Placenta and Decidua Am. J. Pathol., July 1, 2002; 161(1): 105 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Carpenter Variable Degrees of 1-{alpha} Hydroxylase Activity--Fine Tuning the Rachitic Rheostat J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2421 - 2423. [Full Text] [PDF] |
||||
![]() |
U. Segersten, P. Correa, M. Hewison, P. Hellman, H. Dralle, T. Carling, G. Akerstrom, and G. Westin 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Expression in Normal and Pathological Parathyroid Glands J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2967 - 2972. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zehnder, R. Bland, R. S. Chana, D. C. Wheeler, A. J. Howie, M. C. Williams, P. M. Stewart, and M. Hewison Synthesis of 1,25-Dihydroxyvitamin D3 by Human Endothelial Cells Is Regulated by Inflammatory Cytokines: A Novel Autocrine Determinant of Vascular Cell Adhesion J. Am. Soc. Nephrol., March 1, 2002; 13(3): 621 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. H. Zhang, X. Wang, J. T. Wang, N. A. Compagnone, S. H. Mellon, J. L. Olson, H. S. Tenenhouse, W. L. Miller, and A. A. Portale Dietary Phosphorus Transcriptionally Regulates 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Gene Expression in the Proximal Renal Tubule Endocrinology, February 1, 2002; 143(2): 587 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. GOTO, K. MIZUNASHI, N. KIMURA, and Y. FURUKAWA Decreased Sensitivity of Distal Nephron and Collecting Duct to Parathyroid Hormone in Pseudohypoparathyroidism Type I J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1965 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamagata, A. Kimoto, T. Michigami, M. Nakayama, and K. Ozono Hydroxylases Involved in Vitamin D Metabolism Are Differentially Expressed in Murine Embryonic Kidney: Application of Whole Mount in Situ Hybridization Endocrinology, July 1, 2001; 142(7): 3223 - 3230. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zehnder, R. Bland, M. C. Williams, R. W. McNinch, A. J. Howie, P. M. Stewart, and M. Hewison Extrarenal Expression of 25-Hydroxyvitamin D3-1{{alpha}}-Hydroxylase J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 888 - 894. [Abstract] [Full Text] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673